Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Diagnosis, Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07765316
What this trial is testing

Targeting Pathogenic Myelopoiesis in Pancreatic Cancer

Who this might be right for
Pancreatic Diseases
IRCCS San Raffaele 100
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00031694
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
National Cancer Institute (NCI) 19
Not applicableUnknownNCT02121366
What this trial is testing

EUS-guided Ethanol Ablation of an Insulinoma

Who this might be right for
Insulinoma
Guangxi Medical University 50
Not applicableStudy completedNCT02406846
What this trial is testing

The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.

Who this might be right for
Neoplastic Cells, Circulating
Fuda Cancer Hospital, Guangzhou 80
Testing effectiveness (Phase 2)Looking for participantsNCT06922591
What this trial is testing

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Who this might be right for
PDACPDAC - Pancreatic Ductal AdenocarcinomaNSCLC+5 more
Tango Therapeutics, Inc. 183
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Testing effectiveness (Phase 2)Study completedNCT02047474
What this trial is testing

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage I Pancreatic Cancer+2 more
Yale University 46
Not applicableLooking for participantsNCT06263088
What this trial is testing

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Who this might be right for
Gastrointestinal CancerColon CancerRectal Cancer+7 more
Case Comprehensive Cancer Center 200
Early research (Phase 1)Looking for participantsNCT06816823
What this trial is testing

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 30
Not applicableLooking for participantsNCT07554560
What this trial is testing

Nutrition Intervention for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Neuroendocrine Tumor (NET)
Children's Hospital of Philadelphia 18
Early research (Phase 1)Study completedNCT01351103
What this trial is testing

LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Who this might be right for
Pancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Not applicableUnknownNCT04134832
What this trial is testing

Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region

Who this might be right for
Pancreatic Neuroendocrine Tumor
University Hospital, Strasbourg, France 250
Not applicableLooking for participantsNCT07272187
What this trial is testing

Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions

Who this might be right for
Insulinoma; PancreasMEN1NETs+3 more
Herlev Hospital 138
Early research (Phase 1)Ended earlyNCT04117958
What this trial is testing

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers

Who this might be right for
MUC17-positive Solid Tumors
Amgen 58
Next Page